60 Degrees Pharmaceuticals (SXTP): Director bought ~$4.5K
Cheryl Xu, Director at 60 Degrees Pharmaceuticals, bought ~$4.5K of 60 Degrees Pharmaceuticals shares.
- ~$4.5K
- Approx. value · 2,500 sh @ $1.80
- 46K
- Holds after · shares reported
- Traded
- Dec 12, 2024
- Filed
- Dec 19, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 19, 2024InsiderCEO purchased ~$2.2K of SXTP shares in the open market
- Nov 20, 2024InsiderCEO purchased ~$924 of SXTP shares in the open market
- Nov 21, 2024InsiderCEO purchased ~$3.2K of SXTP shares in the open market
- Dec 5, 2024InsiderCEO purchased ~$20K of SXTP shares in the open market
- Dec 6, 2024InsiderCEO purchased ~$25K of SXTP shares in the open market
- Dec 9, 2024InsiderCEO purchased ~$46K of SXTP shares in the open market
- Dec 12, 2024 · this disclosureInsiderDirector purchased ~$4.5K of SXTP shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for 60 Degrees Pharmaceuticals
OQRO holds no insider, Congress, fund or contract record for 60 Degrees Pharmaceuticals dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SXTP page.
Other recent filings by Cheryl Xu, Director
- SEC Form 4 at 60 Degrees Pharmaceuticals (SXTP)Jun 6, 2025
- SEC Form 4 at 60 Degrees Pharmaceuticals (SXTP)Jun 6, 2025
- SEC Form 4 at 60 Degrees Pharmaceuticals (SXTP)Dec 19, 2024
- SEC Form 4 at 60 Degrees Pharmaceuticals (SXTP)Dec 19, 2024
- SEC Form 4 at 60 Degrees Pharmaceuticals (SXTP)Dec 19, 2024
The full history of Cheryl Xu, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which 60 Degrees Pharmaceuticals (SXTP) insider traded, and how much?
Cheryl Xu, Director at 60 Degrees Pharmaceuticals, bought ~$4.5K of 60 Degrees Pharmaceuticals shares. 2,500 shares at $1.80, open market.
When did it happen, and when was it made public?
Traded: Dec 12, 2024. Filed: Dec 19, 2024. That is 7 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
Does this mean SXTP stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at 60 Degrees Pharmaceuticals
- SEC Form 4Jun 16, 2026
- SEC Form 4Dec 17, 2025
- SEC Form 4Dec 12, 2025
- SEC Form 4Dec 12, 2025
- SEC Form 4Jun 6, 2025
- SEC Form 4Jun 6, 2025
Everything OQRO holds on this company is on its SXTP page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data